Clinical Trial: A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07759245) titled 'A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)' on Aug. 07.

Brief Summary: The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximately one year.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Pulmonary Disease, Chronic Obstructive

Intervention: DRUG: Brenipatide

Brenipatide administered SC

DRUG: Placebo

Pla...